StrainX Bioworks
PrivateLast Round
Series A
May 25, 2026
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
StrainX Bioworks is a biotechnology company that develops alternative proteins and other bio-based ingredients using a synthetic biology and precision fermentation platform for the food, nutrition, healthcare, and cosmetic industries.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StrainX Bioworks Comparables
Compare StrainX Bioworks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Happy Hemp Co | 85% | |
| WNC | 83% | |
| Apotheca | 83% |
StrainX Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 25, 2026 |
StrainX Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leo Capital | Series A |
| WindT Angels | Series A |
| IIT Delhi Angels | Series A |
| Good Startup | Series A |
| Dholakia Ventures | Series A |
| Prime Venture Partners | Series A |
| Sparrow Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
$13M round led by Leo Capital and Prime Venture Partners.
StrainX Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about StrainX Bioworks's valuation, stock price, and market status.
Is StrainX Bioworks a public or private company?
StrainX Bioworks is a private company.
What is the current stock price of StrainX Bioworks?
StrainX Bioworks is a private company with no public stock price. No recent secondary market data is available.
How much is StrainX Bioworks worth (valuation)?
Valuation information for StrainX Bioworks is not publicly available.
Can I buy StrainX Bioworks stock?
StrainX Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was StrainX Bioworks's last funding round?
StrainX Bioworks's most recent funding round was Series A on May 25, 2026.
Who are the main investors in StrainX Bioworks?
Key investors in StrainX Bioworks include Leo Capital, Prime Venture Partners.
Will StrainX Bioworks IPO soon?
No public IPO plans have been announced for StrainX Bioworks.
How can I track StrainX Bioworks secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StrainX Bioworks's secondary market activity and sign up for updates.